Image

Adherence and Feasibility of Remote Rehabilitation for Chronic Patellofemoral Joint Pain: a Randomized Controlled Trial

Adherence and Feasibility of Remote Rehabilitation for Chronic Patellofemoral Joint Pain: a Randomized Controlled Trial

Recruiting
All
Phase N/A

Powered by AI

Overview

This study is a prospective, single-center trial involving 66 patients diagnosed with patellofemoral pain. The study adhered to ethical guidelines and obtained informed consent from all participants. Participants were randomly assigned to receive face-to-face remote rehabilitation guidance either 1 time, 3 times, or 6 times. The primary outcome measure was exercise adherence assessed using the Exercise Rating Scale (EARS) after 6 weeks of rehabilitation. Secondary outcomes included knee pain severity, muscle strength, knee function, fatigue levels, and a qualitative research questionnaire. An isokinetic strength testing system was used to measure the open-chain strength of the quadriceps muscle.

Description

The inestigators conducted a forward-looking, single-center pilot study with a follow-up period of 8 weeks. The study recruited 66 patients diagnosed with patellofemoral pain (PFP) by a professional sports physician at the Department of Sports Medicine, Peking University Third Hospital, between January and September 2023. The study adhered to the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee of Peking University Third Hospital. Although this is a pilot study, the inestigators strictly followed the CONSORT guidelines. All participants signed an informed consent form and completed home rehabilitation interventions.

Inclusion and Exclusion Criteria During the trial, an investigator not involved in the study used an electronically generated random sequence to assign patients to three groups. Two professional physical therapists (N.C and S.R) were responsible for assessing and supervising the accuracy of the project and were unaware of the grouping details.

Interventions After randomization, participants received a package containing two wearable motion sensors, a charger, resistance bands, and a manual. Additionally, the rehabilitation software provided lectures and Q&A sessions related to the condition, accessible via Android or iOS platforms. All data collected by the sensors were strictly encrypted to protect patient information and privacy. Each participant was assigned a therapist for home rehabilitation support, and a follow-up function via the software or telephone was used to remind patients who missed three remote rehabilitation sessions.

Before starting home rehabilitation, patients attended a briefing at the hospital. Participants were divided into three groups: Group 1 received 1 face-to-face remote rehabilitation tutorial (OST), Group 2 received 3 face-to-face remote rehabilitation tutorials (TST), and Group 3 received 6 face-to-face remote rehabilitation tutorials (SST). Each session lasted 40 minutes and was conducted three times a week (on Tuesday, Thursday, and Saturday). Following the briefing, patients performed home remote rehabilitation training on the same day, with each session lasting 40 minutes. The remote rehabilitation program included muscle strengthening, flexibility stretching, and movement quality training.

Primary Outcome The primary outcome was assessed by the Exercise Adherence Rating Scale (EARS) 6 weeks after completing the rehabilitation guidance. The scale consists of Part A, which directly assesses adherence (including 6 questions, each with 5 options, scoring from 0 to 4), and Part B, which assesses reasons affecting adherence (including 10 questions, each with 5 options, scoring from 0 to 4). Items with positive phrasing were reverse scored, so a higher overall adherence score indicates better exercise adherence.

Secondary Outcomes Secondary outcomes were collected at the hospital 8 weeks after the start of the study, including knee pain severity assessed by the Visual Analog Scale (VAS) (ranging from 0 "no pain" to 10 "worst pain"); isokinetic concentric and eccentric peak torque of the quadriceps muscle reflecting knee joint muscle strength; Kujala Patellofemoral Score (0 to 100 points, with higher scores indicating better knee function); and the Fatigue Severity Scale (FSS), which measures the severity of fatigue in patients with various conditions and its impact on activities and lifestyle (including 9 questions, each scored from 1 to 7, with higher scores indicating greater fatigue). Additionally, after completing the remote rehabilitation program, the inestigators conducted a qualitative research questionnaire to explore potential strategies to improve adherence.

Eligibility

Inclusion Criteria:

  • (1) Anterior knee pain or retro-patellar pain caused by at least two of the following activities: prolonged sitting with knee flexion, bilateral squatting, ascending and descending stairs, kneeling, running, and jumping;
  • (2) presence of one of the following signs: patellar tenderness, friction pain, or twitching pain, positive single-leg squat test, or positive knee extension resistance test;
  • (3) knee pain lasting more than 3 months;
  • (4) knee pain score greater than 3 out of 10 on the VAS;
  • (5) unilateral pain and symptoms.

Exclusion Criteria:

  • (1) acute injury of the knee ligaments, joint capsule, bursa or meniscus;
  • (2) knee extension or flexion contracture deformity, thus being unable to perform normal lower limb flexion and extension;
  • (3) patellofemoral joint dislocation or subluxation;
  • (4) any traumatic, inflammatory or infectious disease of the lower limbs;
  • (5) a history of knee surgery;
  • (6) a history of cardiovascular and cerebrovascular diseases, diabetes, tumors;
  • (7) spinal cord or neurological injury.

Study details
    Patellofemoral Pain

NCT06651996

Peking University Third Hospital

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.